Results 81 to 90 of about 877 (137)
Bioprosthetic valve failure is a growing clinical challenge, particularly in younger patients with comorbidities. Transcatheter valve-in-valve implantation is an alternative to redo surgery but may fail in cases of severe calcification or infection.A 37-year-old man with systemic lupus erythematosus and end-stage renal disease on hemodialysis presented
AlOtaiby, Khaled +2 more
openaire +2 more sources
Percutaneous Tricuspid Valve-in-Valve Implantation With Melon Seeding During Deployment
Background: Bioprosthetic tricuspid valves are prone to structural deterioration over time. In patients with multiple prior sternotomies and functioning left-sided prostheses, repeat surgery may carry prohibitive risk, prompting consideration of ...
Alexander M. Sellers, MB BCh, BAO +7 more
doaj +1 more source
Introduction: The main disadvantage of bioprosthetic valves is the susceptibility of their leaflets to structural changes, leading to bioprosthetic valve dysfunction requiring a repeated surgical intervention.
S. S. Babeshko +4 more
doaj +1 more source
The porcine bioprosthetic valve
Donald J. Magilligan +3 more
openaire +1 more source
Thrombosis of Bioprosthetic Valves
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Updates on bioprosthetic valve fracture
Expert Review of Cardiovascular Therapy, 2023Valve-in-valve (VIV) transcatheter valve replacement has emerged as a feasible and potentially safer treatment option for failed bioprosthetic surgical valves (BSVs). However, the VIV procedure carries an inherent risk of prosthesis-patient mismatch (PPM).
Shiv, Bagga, Adnan K, Chhatriwalla
openaire +2 more sources
Tricuspid valve replacement with a bioprosthetic valve
Multimedia Manual of Cardio-Thoracic Surgery, 2008Significant tricuspid regurgitation (TR) is present in many patients with heart failure. Valve replacement is necessary in patients in whom the valve is irreparable or in whom there is a high risk of late failure. The following manuscript and videos describe our approach to tricuspid valve replacement with a bioprosthetic valve.
Hyde M, Russell +4 more
openaire +2 more sources
Bioprosthetic valve replacement in the elderly
European Heart Journal, 1995One hundred and ten patients aged more than 65 years (mean, 73.4; range, 65-82) underwent successful bioprosthetic valve replacement (aortic, n = 71; mitral, n = 32; both, n = 7) from 1979 to 1985. The valve was pericardial in 39 cases and porcine in 78. The mean follow-up was 75 months (total, 688 patient-years; range, 2 months to 12 years). Actuarial
G, Helft +7 more
openaire +2 more sources
Deterioration of Bioprosthetic Heart Valves
ASAIO Journal, 1994The aim of this study was to detect biologic factors in the structural deterioration of bioprosthetic heart valves. Prostheses were removed from patients after 4-8 years of implantation and submitted to biochemical and morphologic assays. Successive staining of biologic sections revealed colocalization of lipids and glycosaminoglycans underneath ...
M, Moczar +5 more
openaire +2 more sources
Pathology of bioprosthetic cardiac valves
Human Pathology, 1987.A description of the normal and abnormal anatomic features of bioprosthetic cardiac valves (BP) is ~rese~ted in this article, .with emphasis on cuspal calclficat~on. and perforatlo~, which are their major c~mphcatIons. The following types of bioprosthetic (tissue) heart valves are considered: porcine aortic valvular b~oprostheses (~erein referred to ...
V J, Ferrans +4 more
openaire +2 more sources

